Diagnostic accuracy of CRISPR technology for detecting SARS-CoV-2: a systematic review and meta-analysis

References

• WHO. 2020. Coronavirus disease (COVID-19). https://www.who.int/health-topics/coronavirus#tab=tab_1.
   Google Scholar
• Ciotti M, Angeletti S, Minieri M, et al. COVID-19 outbreak: an overview. Chemotherapy. 2019;64(5–6):215–223.
   PubMed Web of Science ®Google Scholar
• WHO. COVID-19 weekly epidemiological update. 2021. [cited 2021 Jul 20]. https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19.
   Google Scholar
• Han T, Cong H, Shen Y, et al. Recent advances in detection technologies for COVID-19. Talanta. 2021 Oct 1;233:122609
   PubMed Web of Science ®Google Scholar
• Li Y, Yao L, Li J, et al. Stability issues of RT-PCR testing of SARS-CoV-2 for hospitalized patients clinically diagnosed with COVID-19. J Med Virol. 2020 Jul;92(7):903–908.
   PubMed Web of Science ®Google Scholar
• Palaz F, Kalkan AK, Tozluyurt A, et al. CRISPR-based tools: alternative methods for the diagnosis of COVID-19. Clin Biochem. 2021 Mar;89:1–13.
   PubMed Web of Science ®Google Scholar
• Woloshin S, Patel N, Kesselheim AS. False negative tests for SARS-CoV-2 infection - challenges and implications. N Engl J Med. 2020 Aug 6;383(6):e38.
   PubMed Web of Science ®Google Scholar
• Cong L, Ran FA, Cox D, et al. Multiplex genome engineering using CRISPR/Cas systems. Science. 2013 Feb 15;339(6121):819–823.
   PubMed Web of Science ®Google Scholar
• Kumar P, Malik YS, Ganesh B, et al. CRISPR-Cas system: an approach with potentials for COVID-19 diagnosis and therapeutics. Front Cell Infect Microbiol. 2020 Nov 2;10:576875.
   PubMed Web of Science ®Google Scholar
• Ishino Y, Shinagawa H, Makino K, et al. Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product. J Bacteriol. 1987 Dec;169(12):5429–5433.
   PubMed Web of Science ®Google Scholar
• Li Y, Li S, Wang J, et al. CRISPR/Cas Systems towards next-generation biosensing. Trends Biotechnol. 2019 Jul;37(7):730–743.
   PubMed Web of Science ®Google Scholar
• Rahman MR, Hossain MA, Mozibullah M, et al. CRISPR is a useful biological tool for detecting nucleic acid of SARS-CoV-2 in human clinical samples. Biomed Pharmacother. 2021 Aug;140:111772.
   PubMed Web of Science ®Google Scholar
• Koonin EV, Makarova KS, Zhang F. Diversity, classification and evolution of CRISPR-Cas systems. Curr Opin Microbiol. 2017 Jun;37:67–78.
   PubMed Web of Science ®Google Scholar
• Kim S, Ji S, Koh HR. CRISPR as a diagnostic tool. Biomolecules. 2021 Aug 6; 11(8):1162.
   PubMed Web of Science ®Google Scholar
• Aman R, Mahas A, Mahfouz M. Nucleic acid detection using CRISPR/Cas biosensing technologies. ACS Synth Biol. 2020 Jun 19;9(6):1226–1233.
   PubMed Web of Science ®Google Scholar
• Li H, Dong X, Wang Y, et al. Sensitive and easy-read CRISPR strip for COVID-19 rapid point-of-care testing. CRISPR J. 2021 Jun;4(3):392–399.
   PubMedGoogle Scholar
• Cao Y, Wu J, Pang B, et al. CRISPR/Cas12a-mediated gold nanoparticle aggregation for colorimetric detection of SARS-CoV-2. Chem Commun (Camb). 2021 Jul 13;57(56):6871–6874.
   PubMed Web of Science ®Google Scholar
• Garcia-Venzor A, Rueda-Zarazua B, Marquez-Garcia E, et al. SARS-CoV-2 direct detection without RNA isolation with loop-mediated isothermal amplification (LAMP) and CRISPR-Cas12. Front Med (Lausanne). 2021 Feb 17;8:627679.
   PubMed Web of Science ®Google Scholar
• Ding X, Yin K, Li Z, et al. Ultrasensitive and visual detection of SARS-CoV-2 using all-in-one dual CRISPR-Cas12a assay. Nat Commun. 2020 Sep 18;11(1):4711.
   PubMed Web of Science ®Google Scholar
• Page MJ, Moher D, and Bossuyt PM, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ 2021 Mar 29;372:n160.
   PubMed Web of Science ®Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021 Mar 29;372:n71.
   PubMedGoogle Scholar
• Rauch JN, Valois E, Solley SC, et al. A scalable, easy-to-deploy protocol for Cas13-based detection of SARS-CoV-2 genetic material. J Clin Microbiol. 2021 Mar 19;59(4):e02402–20.
   PubMed Web of Science ®Google Scholar
• Tian T, Shu B, Jiang Y, et al. An ultralocalized Cas13a assay enables universal and nucleic acid amplification-free single-molecule RNA diagnostics. ACS Nano. 2021 Jan 26;15(1):1167–1178.
   PubMed Web of Science ®Google Scholar
• Wu H, Chen Y, Shi Y, et al. Carrying out pseudo dual nucleic acid detection from sample to visual result in a polypropylene bag with CRISPR/Cas12a. Biosens Bioelectron. 2021 Apr 15;178:113001.
   PubMed Web of Science ®Google Scholar
• Chen Y, Shi Y, Chen Y, et al. Contamination-free visual detection of SARS-CoV-2 with CRISPR/Cas12a: a promising method in the point-of-care detection. Biosens Bioelectron. 2020 Dec 1;169:112642.
   PubMed Web of Science ®Google Scholar
• Broughton JP, Deng X, Yu G, et al. CRISPR-Cas12-based detection of SARS-CoV-2. Nat Biotechnol. 2020 Jul;38(7):870–874.
   PubMed Web of Science ®Google Scholar
• Zhou H, Tsou JH, Chinthalapally M, et al. Detection and differentiation of SARS-CoV-2, influenza, and respiratory syncytial viruses by CRISPR. diagnostics (Basel). Diagnostics (Basel, Switzerland). 2021 May 1;11(5):823.
   PubMedGoogle Scholar
• Jiang Y, Hu M, Liu AA, et al. Detection of SARS-CoV-2 by CRISPR/Cas12a-enhanced colorimetry. ACS Sens. 2021 Mar 26;6(3):1086–1093.
   PubMed Web of Science ®Google Scholar
• Mayuramart O, Nimsamer P, Rattanaburi S, et al. Detection of severe acute respiratory syndrome coronavirus 2 and influenza viruses based on CRISPR-Cas12a. Exp Biol Med (Maywood). 2021 Feb;246(4):400–405.
   PubMed Web of Science ®Google Scholar
• Park JS, Hsieh K, Chen L, et al. Digital CRISPR/Cas-assisted assay for rapid and sensitive detection of SARS-CoV-2. Adv Sci (Weinh). 2021 Jan 12;8(5):2003564.
   PubMedGoogle Scholar
• Ramachandran A, Huyke DA, Sharma E, et al. Electric field-driven microfluidics for rapid CRISPR-based diagnostics and its application to detection of SARS-CoV-2. Proc Natl Acad Sci U S A. 2020 Nov 24; 117(47):29518–29525.
   PubMed Web of Science ®Google Scholar
• Curti LA, Primost I, Valla S, et al. Evaluation of a lyophilized CRISPR-Cas12 assay for a sensitive, specific, and rapid detection of SARS-CoV-2. Viruses. 2021 Mar 5;13(3):420.
   PubMed Web of Science ®Google Scholar
• Santiago-Frangos A, Hall LN, Nemudraia A, et al. Intrinsic signal amplification by type III CRISPR-cas systems provides a sequence-specific SARS-CoV-2 diagnostic. Cell Rep Med. 2021 Jun 15;2(6):100319.
   PubMedGoogle Scholar
• Pang B, Xu J, Liu Y, et al. Isothermal amplification and ambient visualization in a single tube for the detection of SARS-CoV-2 using loop-mediated amplification and CRISPR technology. Anal Chem. 2020 Dec 15;92(24):16204–16212.
   PubMed Web of Science ®Google Scholar
• Ma P, Meng Q, Sun B, et al. MeCas12a, a highly sensitive and specific system for COVID-19 detection. Adv Sci (Weinh). 2020 Sep 23;7(20):2001300.
   PubMedGoogle Scholar
• Sun Y, Yu L, Liu C, et al. One-tube SARS-CoV-2 detection platform based on RT-RPA and CRISPR/Cas12a. J Transl Med. 2021 Feb 16;19(1):74.
   PubMed Web of Science ®Google Scholar
• Wang R, Qian C, Pang Y, et al. opvCRISPR: one-pot visual RT-LAMP-CRISPR platform for SARS-cov-2 detection. Biosens Bioelectron. 2021 Jan 15;172:112766.
   PubMed Web of Science ®Google Scholar
• Azhar M, Phutela R, Kumar M, et al. Rapid and accurate nucleobase detection using FnCas9 and its application in COVID-19 diagnosis. Biosens Bioelectron. 2021 Jul 1;183:113207.
   PubMed Web of Science ®Google Scholar
• Tsou JH, Liu H, Stass SA, et al. Rapid and sensitive detection of SARS-CoV-2 using clustered regularly interspaced short palindromic repeats. Biomedicines. 2021 Feb 27;9(3):239.
   PubMed Web of Science ®Google Scholar
• Xiong D, Dai W, Gong J, et al. Rapid detection of SARS-CoV-2 with CRISPR-Cas12a. PLoS Biol. 2020 Dec 15 18(12):e3000978.
   PubMed Web of Science ®Google Scholar
• Zhu X, Wang X, Li S, et al. Rapid, ultrasensitive, and highly specific diagnosis of COVID-19 by CRISPR-Based detection. ACS Sens. 2021 Mar 26;6(3):881–888.
   PubMed Web of Science ®Google Scholar
• Silva FSR, Erdogmus E, Shokr A, et al. SARS-CoV-2 RNA detection by a cellphone-based amplification-free system with CRISPR/CAS-dependent enzymatic (CASCADE) assay. Adv Mater Technol. 2021 Jul 19;6(12):2100602.
   PubMed Web of Science ®Google Scholar
• Ding X, Yin K, Li Z, et al. Sensitive quantitative detection of SARS-CoV-2 in clinical samples using digital warm-start CRISPR assay. Biosens Bioelectron. 2021 Jul 15;184:113218.
   PubMed Web of Science ®Google Scholar
• Xiong E, Jiang L, Tian T, et al. Simultaneous dual-gene diagnosis of SARS-CoV-2 based on CRISPR/Cas9-mediated lateral flow assay. Angew Chem Int Ed Engl. 2021 Mar 1;60(10):5307–5315.
   PubMed Web of Science ®Google Scholar
• Arizti-Sanz J, Freije CA, Stanton AC, et al. Streamlined inactivation, amplification, and Cas13-based detection of SARS-CoV-2. Nat Commun. 2020 Nov 20;11(1):5921.
   PubMed Web of Science ®Google Scholar
• Huang Z, Tian D, Liu Y, et al. Ultra-sensitive and high-throughput CRISPR-p owered COVID-19 diagnosis. Biosens Bioelectron. 2020 Sep 15;164:112316.
   PubMed Web of Science ®Google Scholar
• Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011 Oct 18;155(8):529–536.
   PubMed Web of Science ®Google Scholar
• Jiao C, Sharma S, Dugar G, et al. Noncanonical crRNAs derived from host transcripts enable multiplexable RNA detection by Cas9. Science. 2021 May 28;372(6545):941–948.
   PubMed Web of Science ®Google Scholar
• Chen JS, Ma E, Harrington LB, et al. CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity. Science. 2018 Apr 27;360(6387):436–439.
   PubMed Web of Science ®Google Scholar
• Gootenberg JS, Abudayyeh OO, Kellner MJ, et al. Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6. Science. 2018 Apr 27;360(6387):439–444.
   PubMed Web of Science ®Google Scholar
• Zhou W, Yang H, Zhou L, et al. Dynamics of grassland carbon sequestration and its coupling relation with hydrothermal factor of Inner Mongolia. Ecol Indic. 2018;95:1–11.
   Web of Science ®Google Scholar
• Gong S, Zhang S, Lu F, et al. CRISPR/Cas-based in vitro diagnostic platforms for cancer biomarker detection. Anal Chem. 2021 Sep 7;93(35):11899–11909.
   PubMed Web of Science ®Google Scholar
• Ahmed MZ, Badani P, Reddy R, et al. CRISPR/Cas advancement in molecular diagnostics and signal readout approaches. J Mol Diagn. 2021 Aug 25;S1525-1578(21):00261.
   Google Scholar
• Adli M. The CRISPR tool kit for genome editing and beyond. Nat Commun. 2018 May 15;9(1):1911.
   PubMedGoogle Scholar
• Makarova KS, Wolf YI, Iranzo J, et al. Evolutionary classification of CRISPR-Cas systems: a burst of class 2 and derived variants. Nat Rev Microbiol. 2020 Feb;18(2):67–83.
   PubMed Web of Science ®Google Scholar
• Zetsche B, Gootenberg JS, Abudayyeh OO, et al. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell. 2015 Oct 22;163(3):759–771.
   PubMed Web of Science ®Google Scholar
• Abudayyeh OO, Gootenberg JS, Konermann S, et al. C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector. Science. 2016 Aug 5;353(6299):aaf5573.
   PubMed Web of Science ®Google Scholar
• Paul B, Montoya G. CRISPR-Cas12a: functional overview and applications. Biomed J. 2020 Feb;43(1):8–17.
   PubMed Web of Science ®Google Scholar
• Wu H, He JS, Zhang F, et al. Contamination-free visual detection of CaMV35S promoter amplicon using CRISPR/Cas12a coupled with a designed reaction vessel: rapid, specific and sensitive. Anal Chim Acta. 2020 Feb 1;1096:130–137.
   PubMed Web of Science ®Google Scholar
• Li Y, Mansour H, Watson CJF, et al. Amplified detection of nucleic acids and proteins using an isothermal proximity CRISPR Cas12a assay. Chem Sci. 2021 Jan 4;12(6):2133–2137.
   PubMed Web of Science ®Google Scholar
• van Dongen Je, Berendsen JTW, Steenbergen JTW, et al. Point-of-care CRISPR/Cas nucleic acid detection: recent advances, challenges and opportunities. Biosens Bioelectron. 2020 Oct 15;166:112445.
   PubMed Web of Science ®Google Scholar
• Le Bert N, Tan AT, Kunasegaran K, et al. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature. 2020 Aug;584(7821):457–462.
   PubMed Web of Science ®Google Scholar
• Yu F, Yan L, Wang N, et al. Quantitative detection and viral load analysis of SARS-CoV-2 in infected patients. Clin Infect Dis. 2020 Jul 28;71(15):793–798.
   PubMed Web of Science ®Google Scholar
• Hirotsu Y, Maejima M, Shibusawa M, et al. Comparison of automated SARS-CoV-2 antigen test for COVID-19 infection with quantitative RT-PCR using 313 nasopharyngeal swabs, including from seven serially followed patients. Int J Infect Dis. 2020 Oct;99:397–402.
   PubMed Web of Science ®Google Scholar
• Hanson KE, Barker AP, Hillyard DR, et al. Self-collected anterior nasal and saliva specimens versus health care worker-collected nasopharyngeal swabs for the molecular dDetection of SARS-CoV-2. J Clin Microbiol. 2020 Oct 21;58(11):e01824–20.
   PubMed Web of Science ®Google Scholar
• Homza M, Zelena H, Janosek J, et al. Performance of seven SARS-CoV-2 self-Tests based on saliva, anterior nasal and nasopharyngeal swabs corrected for infectiousness in real-life conditions: a cross-sectional test accuracy study. Diagnostics (Basel). 2021 Aug 28;11(9):1567.
   PubMedGoogle Scholar
• Azzi L, Maurino V, Baj A, et al. Diagnostic salivary tests for SARS-CoV-2. J Dent Res. 2021 Feb;100(2):115–123.
   PubMed Web of Science ®Google Scholar
• Chen JH, Yip CC, Poon RW, et al. Evaluating the use of posterior oropharyngeal saliva in a point-of-care assay for the detection of SARS-CoV-2. Emerg Microbes Infect. 2020 Dec;9(1):1356–1359.
   PubMed Web of Science ®Google Scholar
• Chudy M, Weber-Schehl M, Pichl L, et al. Blood screening nucleic acid amplification tests for human immunodeficiency virus Type 1 may require two different amplification targets. Transfusion. 2012 Feb;52(2):431–439.
   PubMed Web of Science ®Google Scholar
• Lee HK, Lee CK, Loh TP, et al. Diagnostic testing for pandemic influenza in Singapore: a novel dual-gene quantitative real-time RT-PCR for the detection of influenza A/H1N1/2009. J Mol Diagn. 2010 Sep;12(5):636–643.
   PubMed Web of Science ®Google Scholar
• Tian T, Shu B, Jiang Y, et al. An Ultralocalized Cas13a assay enables universal and nucleic acid amplification-free single-molecule RNA diagnostics. ACS Nano. 2021;15(1):1167–1178.
   PubMed Web of Science ®Google Scholar
• Hillary VE, Ignacimuthu S, Ceasar SA. Potential of CRISPR/Cas system in the diagnosis of COVID-19 infection. Expert Rev Mol Diagn. 2021;21(11):1179–1189.
   PubMed Web of Science ®Google Scholar
• Patchsung M, Jantarug K, Pattama A, et al. Clinical validation of a Cas13-based assay for the detection of SARS-CoV-2 RNA. Nat Biomed Eng. 2020 Dec;4(12):1140–1149.
   PubMed Web of Science ®Google Scholar
• Yao Y, Guo W, Zhang J, et al. Reverse fluorescence enhancement and colorimetric bimodal signal readout immunochromatography test strip for ultrasensitive large-scale screening and postoperative monitoring. ACS Appl Mater Interfaces. 2016 Sep 7;8(35):22963–22970.
   PubMed Web of Science ®Google Scholar
• Yuan C, Tian T, Sun J, et al. Universal and naked-eye gene detection platform based on the clustered regularly interspaced short palindromic repeats/Cas12a/13a system. Anal Chem. 2020 Mar 3;92(5):4029–4037.
   PubMed Web of Science ®Google Scholar